SEIZE THE $50 BILLION SITE-OF-CARE SHIFT OPPORTUNITY
Get the tools, data, and insights to drive growth.
Learn more
RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Daily Briefing

Weekly review: At what age can you expect to gain the most weight?


Whether America will soon see a Covid-19 surge like Europe, what a new study reveals about colonoscopies, and more.

Covid-19 is surging in Europe. Is America next? (Monday, October 10)

While infections, hospitalizations, and deaths from Covid-19 have been steadily declining in the United States in recent months, experts warn that rising cases in Europe may be "a harbinger for what's about to happen in the United States," Rob Stein writes for NPR's "Shots."

'Shock, disappointment, and … disbelief': What a new study reveals about colonoscopies (Tuesday, October 11)

Individuals who underwent colonoscopies had a lower risk of colorectal cancer than those who did not get screened, according to a new study published in the New England Journal of Medicine. However, the reduction in risk was lower than expected, suggesting that a colonoscopy may not be "the magic bullet we thought it was."

Which diet is best? A new tool may help you find out. (Wednesday, October 12)

On Monday, researchers from the University of Washington debuted a new tool in Nature Medicine, which uses a five-star rating system to help users identify diet and lifestyle changes that are supported by evidence, Isabella Cueto writes for STAT.

At what age can you expect to gain the most weight? (Thursday, October 13)

American adults gain weight at different rates depending on their age—and while studying long-term weight gain, researchers were able to determine during which decades of life people put on the most pounds, according to a study published in the Journal of Obesity.

'Everyone wants a quick fix': Inside the controversial use of new weight loss drugs (Friday, October 14)

A new generation of weight loss drugs could have a significant impact on obesity in the United States. But high costs, as well as off-label use from relatively healthy patients, could limit access to the treatments for the patients who need it most.

 

 


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.